Skip to content

Comparative Study of Specular Microscope for Cell Density, Coefficient of Variation, Hexagonality and Corneal Thickness

Comparative Study of Specular Microscopes for the Measurement of Endothelial Cell Densities, Coefficient of Variation of Endothelial Cell Area, %Hexagonality, and Central Corneal Thickness

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01729975
Enrollment
80
Registered
2012-11-21
Start date
2012-10-31
Completion date
Unknown
Last updated
2012-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal and Endothelial Cell Measurements

Brief summary

The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Nidek Specular Microscope CEM-530. The secondary objective is to evaluate any adverse events found during the clinical study.

Interventions

None listed

Sponsors

Nidek Co. LTD.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Non-Pathologic: Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who follow the instructions by Principal/Clinical investigator or clinical staff at the clinical site, and can visit on a scheduled examination date. * Pathologic: Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who follow the instructions by Principal/Clinical investigator or clinical staff at the clinical site, and can visit on a scheduled examination date and subjects who have any of the following conditions: * History of Post-op surgical trauma including, Psudophakic or Aphakic blous keratopathy or glaucoma surgery * History of corneal transplant * Physical injury or trauma to the cornea * Long term Fuch's dystrophy/Guttata (and other corneal endothelial dystrophy) * Keratoconus * Long term PMMA contact lens use

Exclusion criteria

* Non-Pathologic subjects who have the following conditions: * Long term Diabetes * Dementia * Subjects who have other life threatening and/or debilitating systemic diseases * History of corneal transplant * Long term Fuch's dystrophy (and other corneal endothelial dystrophy) * Keratoconus * Guttata * Diabetic retinopathy * History of cataract or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device. * All contact lens wearers * Pathologic subjects who have Dementia or who have other life threatening and/or debilitating systemic diseases

Design outcomes

Primary

MeasureTime frameDescription
Corneal and Endothelial Cell Measurementssingle time point - 1 daySubstantial equivalence to a predicate device with respect to corneal and endothelial cell measurements

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026